As May Draws To A Close, BioEngine Sci-Tech Co, Ltd Keeps Accelerating Its Global Footprint

May enters its final week, yet BioEngine Sci-Tech Co, Ltd shows no sign of slowing down. From Nanjing to Beijing in China, then onward to Makuhari in Japan and Sochi in Russia, BioEngine Sci-Tech Co, Ltd hosted four high-profile exhibitions spanning two domestic cities and two overseas countries this May, solidifying its global expansion as a brand delivering "Intelligently Made in China". Throughout the events, we welcomed over a thousand industry peers worldwide. In numerous in-depth technical exchanges, we demonstrated the technological prowess and global vision of a Chinese serum-free culture medium brand to the world.

 

Rooted in Domestic Market: Splendid Presence Across Two Chinese Cities

 

BioEngine Sci-Tech Co, Ltd showcased its self-developed flagship products and cutting-edge technologies at two major domestic industry summits successively: the 25th China Biological Products Conference (CBioPC2026) and the 2026 BPD Beijing Biopharmaceutical Process Development Conference.

 

EVENT 01

Nanjing Station | Deep Process Expertise, Products as Core Technical Solutions

 

At the Nanjing exhibition, BioEngine Sci-Tech Co, Ltd Booth L20 stood out as a central technical hub attracting crowds across the venue. Instead of casual browsing, visitors arrived with specific process challenges for in-depth technical discussions.

Our newly launched products, including UltraFeed CHO Fed-Batch Medium, Vigor-S201 Serum-Free Medium for Insect Cells and Omni-Expansion MSC Culture Kit, drew intensive attention from process development leads at multiple biopharmaceutical enterprises. On-site technical dialogues remained vibrant, with real-world application cases featuring an average 25% yield improvement and superior performance over legacy processes in 90% of projects emerging as hot topics.

 

EVENT 02

Beijing Station | Ecosystem Collaboration & Enhanced Interaction

 

At the Beijing exhibition, BioEngine Sci-Tech Co, Ltd Booth S11 maintained a focus on technical communication. Long-term partners visited to share product usage feedback and process optimization experience, while numerous new visitors stopped by to learn about BioEngine Sci-Tech Co, Ltd's full portfolio of new and established products, as well as integrated process solutions.

Global Outreach: Japan & Russia

If the two domestic exhibitions delivered in-depth technical engagement, the two cross-Eurasian international expos broadened BioEngine Sci-Tech Co, Ltd's global reach.

 

EVENT 03

Japan Station | Quality Recognition Aligned with Rigorous Standards

 

Japan's manufacturing sector is renowned for rigorous pursuit of precision, yet stringent local requirements did not hinder BioEngine Sci-Tech Co, Ltd-instead, they fostered strong technical resonance. BioEngine Sci-Tech Co, Ltd participated in Interphex Japan 2026 from May 20 to 22, the largest pharmaceutical industrial exhibition in Japan and a leading event across Asia. The company witnessed strong market demand from Japanese stakeholders for cost-effective, high-precision bioprocess solutions manufactured in China.

 

EVENT 04

Russia Station | Strategic Breakthrough in Emerging Markets

 

Concurrently, BioEngine Sci-Tech Co, Ltd brought its bioprocess technologies to Eastern Europe at the Sirius Biotech Exhibition held in Sochi, Russia, receiving enthusiastic market feedback for Chinese bioprocess raw materials.

 

Russian buyers adopt highly pragmatic, strategic evaluation criteria when selecting cell culture solutions. During the exhibition, BioEngine Sci-Tech Co, Ltd met a large number of professional visitors and potential regional distributors. We established preliminary cooperation intentions with multiple prospective partners focusing on therapeutic proteins, vaccine production, and cell and gene therapy (CGT) products, laying a solid foundation for deeper market penetration across Eastern Europe.

 

Beyond the Exhibitions

 

From Nanjing to Beijing, Tokyo to Sochi, this journey represents far more than geographic expansion-it stands as tangible execution of BioEngine Sci-Tech Co, Ltd's core strategy: "Rooted in China, Serving the Globe". Regardless of client location or application scenario (therapeutic protein production, vaccine manufacturing, or cell and gene therapy), BioEngine Sci-Tech Co, Ltd consistently delivers reliable solutions to resolve core manufacturing bottlenecks.

 

If you are interested in any products featured at these exhibitions, or were unable to hold detailed discussions with our team on-site, feel free to contact us via official WeChat account message center at any time.